The Coalition for Epidemic Preparedness Innovations (CEPI) recently announced a collaboration with Germany-based IDT Biologika worth up to $36 million to develop and produce a vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV).
The substitution of bedaquiline for second-line injectable antibiotics (SLIs) in a small group of patients with multidrug-resistant tuberculosis (MDR-TB) resulted in improved outcomes, South African researchers report in Clinical Infectious Diseases.
A study today in Pediatrics suggests that a dose of parenteral antibiotics prior to discharge from the emergency department (ED) is likely not necessary for most young children with urinary tract infections (UTIs).
The changes prioritize newer medications and oral regimens over injectable drugs.
The Democratic Republic of the Congo's (DRC's) ministry of health confirmed that the new Ebola outbreak in the eastern reaches of the country is caused by the Zaire Ebola virus species, according to Science magazine.
US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, today announced the formation of a new task force to address drug shortages and long-term strategies for preventing them.
A new study by researchers with a health system in Detroit indicates that a small, behavioral "nudge" in microbiology reporting increased de-escalation and discontinuation of unnecessary broad-spectrum antibiotics in pneumonia patients. The results were reported in Open Forum Infectious Diseases.
"Our results justify consideration for revised recommendations from WHO and wider use of bedaquiline," the authors write.
In what appears to be an underreported outbreak, officials with Public Health England (PHE) yesterday in Eurosurveillance detailed 118 laboratory-confirmed cases of high-level azithromycin-resistant Neisseria gonorrhoeae, noting that cases emerged among heterosexuals in Leeds but then spread across England and into networks of men who have sex with men (MSM).
CARB-X is adding another diagnostic system to its growing portfolio of products targeting drug-resistant bacteria.
